Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Proposition Surrounding the New Oral GnRH Antagonists

Host: Lee P. Shulman, MD, FACMG, FACOG

Guest: Andrea S. Lukes, MD, MHSc, FACOG

By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnRH antagonist therapy can dramatically impact pain and bleeding and improve results across all EHP-30 domains. Join Drs. Lee Shulman and Andrea Lukes as they dive into these data and offer strategies to help you better incorporate patient-centric medical management for uterine fibroids and endometriosis into your clinical practice.